1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- MORE
Global Gene Amplification Technologies Market: About this market
The gene amplification technologies market analysis considers sales from medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and other applications. Our analysis also considers the sales of gene amplification technologies in Asia, Europe, North America, and ROW. In 2018, the medical and pharmaceutical segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising prevalence of genetic and infectious conditions and the growing need for drug discovery will play a significant role in the medical and pharmaceutical segment to maintain its market position. Also, our global gene amplification technologies market report looks at factors such as increasing genomic research, substantial adoption of gene amplification technologies in targeted cancer therapies, and low cost of genetic sequencing. However, varying regulatory guidelines on genetic research and testing, requirement for high expertise to perform gene amplification studies, and increasing number of product recalls may hamper the growth of the gene amplification technologies industry over the forecast period.
Global Gene Amplification Technologies Market: Overview
Adoption of gene amplification kits in targeted cancer therapies is being witnessed due to the increasing demand for alternative treatments to chemotherapy. This is also due to the increase in approvals for targeted gene therapies by regulatory authorities. Thus, the increasing development of such therapies to treat various cancers, such as colorectal, cervical, and breast cancer, is expected to trigger the adoption of gene amplification technologies and lead to the expansion of the global gene amplification technologies market at a CAGR of over 9% during the forecast period.
Rising demand for gene amplification kits and assays in consumer genetics
Genetic testing for the identification of disease risks and paternity is performed by reference laboratories using gene multiplexing techniques that involve the use of gene amplification kits and assays. The rising popularity of relationship testing services, such as ancestry testing and paternity testing, has resulted in the high adoption of consumer genetic services, specifically among the millennial population. The demand for determining the risk of cancers through genetic tests has increased due to the rising mortality rates associated with cancers. This has promoted the use of dedicated gene amplification kits in direct-to-consumer testing for cancer risk analyses. These factors are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global gene amplification technologies market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene amplification technologies manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Also, the gene amplification technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The gene amplification technologies market analysis considers sales from medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and other applications. Our analysis also considers the sales of gene amplification technologies in Asia, Europe, North America, and ROW. In 2018, the medical and pharmaceutical segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising prevalence of genetic and infectious conditions and the growing need for drug discovery will play a significant role in the medical and pharmaceutical segment to maintain its market position. Also, our global gene amplification technologies market report looks at factors such as increasing genomic research, substantial adoption of gene amplification technologies in targeted cancer therapies, and low cost of genetic sequencing. However, varying regulatory guidelines on genetic research and testing, requirement for high expertise to perform gene amplification studies, and increasing number of product recalls may hamper the growth of the gene amplification technologies industry over the forecast period.
Global Gene Amplification Technologies Market: Overview
Adoption of gene amplification kits in targeted cancer therapies is being witnessed due to the increasing demand for alternative treatments to chemotherapy. This is also due to the increase in approvals for targeted gene therapies by regulatory authorities. Thus, the increasing development of such therapies to treat various cancers, such as colorectal, cervical, and breast cancer, is expected to trigger the adoption of gene amplification technologies and lead to the expansion of the global gene amplification technologies market at a CAGR of over 9% during the forecast period.
Rising demand for gene amplification kits and assays in consumer genetics
Genetic testing for the identification of disease risks and paternity is performed by reference laboratories using gene multiplexing techniques that involve the use of gene amplification kits and assays. The rising popularity of relationship testing services, such as ancestry testing and paternity testing, has resulted in the high adoption of consumer genetic services, specifically among the millennial population. The demand for determining the risk of cancers through genetic tests has increased due to the rising mortality rates associated with cancers. This has promoted the use of dedicated gene amplification kits in direct-to-consumer testing for cancer risk analyses. These factors are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global gene amplification technologies market is moderately fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gene amplification technologies manufacturers, that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Also, the gene amplification technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Application - Market share 2018-2023 (%)
Exhibit 19: Comparison by application
Exhibit 20: Medical and pharmaceutical - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Medical and pharmaceutical - Year-over-year growth 2019-2023 (%)
Exhibit 22: Forensic and identity testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Forensic and identity testing - Year-over-year growth 2019-2023 (%)
Exhibit 24: Agricultural and food safety - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Agricultural and food safety - Year-over-year growth 2019-2023 (%)
Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Others - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Abbott Laboratories - Vendor overview
Exhibit 49: Abbott Laboratories - Business segments
Exhibit 50: Abbott Laboratories - Organizational developments
Exhibit 51: Abbott Laboratories - Geographic focus
Exhibit 52: Abbott Laboratories - Segment focus
Exhibit 53: Abbott Laboratories - Key offerings
Exhibit 54: Agilent Technologies Inc. - Vendor overview
Exhibit 55: Agilent Technologies Inc. - Business segments
Exhibit 56: Agilent Technologies Inc. - Organizational developments
Exhibit 57: Agilent Technologies Inc. - Geographic focus
Exhibit 58: Agilent Technologies Inc. - Segment focus
Exhibit 59: Agilent Technologies Inc. - Key offerings
Exhibit 60: bioMérieux SA - Vendor overview
Exhibit 61: bioMérieux SA - Business segments
Exhibit 62: bioMérieux SA - Organizational developments
Exhibit 63: bioMérieux SA - Geographic focus
Exhibit 64: bioMérieux SA - Key offerings
Exhibit 65: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 66: Bio-Rad Laboratories Inc. - Business segments
Exhibit 67: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 68: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 69: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 70: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 71: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 72: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 73: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 74: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 75: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 76: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 77: Merck KGaA - Vendor overview
Exhibit 78: Merck KGaA - Business segments
Exhibit 79: Merck KGaA - Organizational developments
Exhibit 80: Merck KGaA - Geographic focus
Exhibit 81: Merck KGaA - Segment focus
Exhibit 82: Merck KGaA - Key offerings
Exhibit 83: PerkinElmer Inc. - Vendor overview
Exhibit 84: PerkinElmer Inc. - Business segments
Exhibit 85: PerkinElmer Inc. - Organizational developments
Exhibit 86: PerkinElmer Inc. - Geographic focus
Exhibit 87: PerkinElmer Inc. - Segment focus
Exhibit 88: PerkinElmer Inc. - Key offerings
Exhibit 89: QIAGEN Group - Vendor overview
Exhibit 90: QIAGEN Group - Product segments
Exhibit 91: QIAGEN Group - Organizational developments
Exhibit 92: QIAGEN Group - Geographic focus
Exhibit 93: QIAGEN Group - Segment focus
Exhibit 94: QIAGEN Group - Key offerings
Exhibit 95: Siemens Healthineers AG - Vendor overview
Exhibit 96: Siemens Healthineers AG - Business segments
Exhibit 97: Siemens Healthineers AG - Organizational developments
Exhibit 98: Siemens Healthineers AG - Geographic focus
Exhibit 99: Siemens Healthineers AG - Segment focus
Exhibit 100: Siemens Healthineers AG - Key offerings
Exhibit 101: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 102: Thermo Fisher Scientific Inc. - Business segments
Exhibit 103: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 104: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 105: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 106: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 107: Validation techniques employed for market sizing
Exhibit 108: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by application
- Comparison by application
- Medical and pharmaceutical - Market size and forecast 2018-2023
- Forensic and identity testing - Market size and forecast 2018-2023
- Agricultural and food safety - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by application
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Increasing quantitative studies on GM crops
- Advent of isothermal DNA amplification
- Rising demand for gene amplification kits and assays in consumer genetics
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN Group
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Application - Market share 2018-2023 (%)
Exhibit 19: Comparison by application
Exhibit 20: Medical and pharmaceutical - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Medical and pharmaceutical - Year-over-year growth 2019-2023 (%)
Exhibit 22: Forensic and identity testing - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Forensic and identity testing - Year-over-year growth 2019-2023 (%)
Exhibit 24: Agricultural and food safety - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Agricultural and food safety - Year-over-year growth 2019-2023 (%)
Exhibit 26: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Others - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Abbott Laboratories - Vendor overview
Exhibit 49: Abbott Laboratories - Business segments
Exhibit 50: Abbott Laboratories - Organizational developments
Exhibit 51: Abbott Laboratories - Geographic focus
Exhibit 52: Abbott Laboratories - Segment focus
Exhibit 53: Abbott Laboratories - Key offerings
Exhibit 54: Agilent Technologies Inc. - Vendor overview
Exhibit 55: Agilent Technologies Inc. - Business segments
Exhibit 56: Agilent Technologies Inc. - Organizational developments
Exhibit 57: Agilent Technologies Inc. - Geographic focus
Exhibit 58: Agilent Technologies Inc. - Segment focus
Exhibit 59: Agilent Technologies Inc. - Key offerings
Exhibit 60: bioMérieux SA - Vendor overview
Exhibit 61: bioMérieux SA - Business segments
Exhibit 62: bioMérieux SA - Organizational developments
Exhibit 63: bioMérieux SA - Geographic focus
Exhibit 64: bioMérieux SA - Key offerings
Exhibit 65: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 66: Bio-Rad Laboratories Inc. - Business segments
Exhibit 67: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 68: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 69: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 70: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 71: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 72: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 73: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 74: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 75: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 76: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 77: Merck KGaA - Vendor overview
Exhibit 78: Merck KGaA - Business segments
Exhibit 79: Merck KGaA - Organizational developments
Exhibit 80: Merck KGaA - Geographic focus
Exhibit 81: Merck KGaA - Segment focus
Exhibit 82: Merck KGaA - Key offerings
Exhibit 83: PerkinElmer Inc. - Vendor overview
Exhibit 84: PerkinElmer Inc. - Business segments
Exhibit 85: PerkinElmer Inc. - Organizational developments
Exhibit 86: PerkinElmer Inc. - Geographic focus
Exhibit 87: PerkinElmer Inc. - Segment focus
Exhibit 88: PerkinElmer Inc. - Key offerings
Exhibit 89: QIAGEN Group - Vendor overview
Exhibit 90: QIAGEN Group - Product segments
Exhibit 91: QIAGEN Group - Organizational developments
Exhibit 92: QIAGEN Group - Geographic focus
Exhibit 93: QIAGEN Group - Segment focus
Exhibit 94: QIAGEN Group - Key offerings
Exhibit 95: Siemens Healthineers AG - Vendor overview
Exhibit 96: Siemens Healthineers AG - Business segments
Exhibit 97: Siemens Healthineers AG - Organizational developments
Exhibit 98: Siemens Healthineers AG - Geographic focus
Exhibit 99: Siemens Healthineers AG - Segment focus
Exhibit 100: Siemens Healthineers AG - Key offerings
Exhibit 101: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 102: Thermo Fisher Scientific Inc. - Business segments
Exhibit 103: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 104: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 105: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 106: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 107: Validation techniques employed for market sizing
Exhibit 108: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- MORE
The following companies are recognised as the key players in the global gene amplification technologies market: Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN Group, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising demand for gene amplification kits and assays in consumer genetics.”
According to the report, one of the major drivers for this market is the substantial adoption of gene amplification technologies in targeted cancer therapies.
Further, the report states that one of the major factors hindering the growth of this market is the requirement for high expertise to perform gene amplification studies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising demand for gene amplification kits and assays in consumer genetics.”
According to the report, one of the major drivers for this market is the substantial adoption of gene amplification technologies in targeted cancer therapies.
Further, the report states that one of the major factors hindering the growth of this market is the requirement for high expertise to perform gene amplification studies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN Group
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
